Republicans are aiming for major reductions in federal spending, and Medicaid seems a likely target. But the politics of ...

The CEOs of CVS Health and UnitedHealth Group praised pharmacy benefit managers and promised transparency during investor ...

The end of federal diversity, equity and inclusion programs in the federal government may have a ripple effect on social ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

A panelist discusses how autoimmune screening through detection of diabetes-specific autoantibodies serves as a critical tool for identifying pre-symptomatic type 1 diabetes (T1D), enabling earlier ...

Eric Cannon, PharmD, FAMCP, discusses how precision medicine advancements and biomarker development can enable targeted ...

Lexeo Therapeutics’ gene therapy provides a healthy version of the frataxin gene, which is critical for energy production in ...

Researchers found that use of immunosuppressive medication was a strong protective factor, associated with a 60% reduction in ...

United Health Foundation, the charitable branch of UnitedHealth Group, awarded more than $7 million in grants to ...

The FDA has set a goal date of Aug. 27, 2025. If approved, the therapy would be branded as Lytenava and be the first ...

Bkemv is being offered at 10% off Soliris, and Epysqli is offered at 30% below Soliris. Both biosimilars treat several of the ...